Back
Compare AU
Compare QHSM vs. CNEW
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck MSCI Intl SML Comp Quality (Aud Hedged) ETF (QHSM) and the VanEck China New Economy ETF (CNEW). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
QHSM | CNEW | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 6 | 66 |
Median incremental investment | $7,500.00 | $824.12 |
Median investment frequency | Monthly | Monthly |
Median total investment | $24,687.04 | $1,917.51 |
Average age group | > 35 | > 35 |
Key Summary
QHSM | CNEW | |
|---|---|---|
Strategy | QHSM.AX was created on 2023-11-07 by VanEck. The fund's investment portfolio concentrates primarily on small cap equity. QHSM.AX gives investors a diversified portfolio of 150 international developed market small-cap quality growth securities with returns hedged into Australian dollars. QHSM.AX aims to provide investment returns before fees and other costs which track the performance of the Index. | CNEW.AX was created on 2018-11-08 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 104.46m in AUM and 122 holdings. CNEW.AX gives investors a portfolio of the most fundamentally sound companies in China having the best growth prospects in sectors making up the New Economy, namely technology, health care, consumer staples and consumer discretionary. CNEW.AX aims to provide investment returns, before fees and other costs, which track the performance of the Index. |
Top 3 holdings | VanEck MSCI Intl Sm Com Qual ETF (100.11 %) | Suzhou Zelgen Biopharmaceuticals Co Ltd Class A (1.31 %) Shanghai Allist Pharmaceuticals Co Ltd Class A (1.19 %) Haisco Pharmaceutical Group Co Ltd Class A (1.19 %) |
Top 3 industries | Information Technology (33.78 %) Health Care (27.01 %) Consumer Discretionary (20.43 %) | |
Top 3 countries | United States (81.15 %) United Kingdom of Great Britain and Northern Ireland (5.19 %) Japan (3.01 %) | China (100.00 %) |
Management fee | 0.62 % | 0.95 % |
Key Summary
QHSM | CNEW | |
|---|---|---|
Issuer | VanEck | VanEck |
Tracking index | MSCI World ex Australia Small Cap Quality 150 Index - AUD - Benchmark TR Net | CSI MarketGrader China New Economy Index - CNY |
Asset class | ETF | ETF |
Management fee | 0.62 % | 0.95 % |
Price | $34.24 | $7.94 |
Size | $270.254 million | $100.985 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.61 % | 1.33 % |
Market | ASX | ASX |
First listed date | 08/11/2023 | 09/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
QHSM | CNEW | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 6 | 66 |
Median incremental investment | $7,500.00 | $824.12 |
Median investment frequency | Monthly | Monthly |
Median total investment | $24,687.04 | $1,917.51 |
Average age group | > 35 | > 35 |
Pros and Cons
QHSM | CNEW | |
|---|---|---|
Pros |
| |
Cons |
|
QHSM | CNEW |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |